LVTX Competitors & Alternatives
Compare LAVA Therapeutics N.V. Ordinary Shares with similar stocks in the same industry
PHARMACEUTICAL PREPARATIONS
LVTX
Main Stock$1.27
Tradestie Score
67
Market Cap
$40.51M
Revenue Growth
13.1%
Analyst Upside
+17.6%
Top Competitors
553 stocks in PHARMACEUTICAL PREPARATIONS| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$886.42
|
$739.95B | 39.1 | 51 | Compare |
|
JNJ
Johnson & Johnson
|
$242.08
|
$448.07B | 21.7 | 61 | Compare |
|
ABBV
ABBVIE INC.
|
$213.05
|
$431.71B | 89.5 | 55 | Compare |
|
NVO
Novo-Nordisk A/S
|
$35.42
|
$262.92B | 10.2 | 57 | Compare |
|
AZN
AstraZeneca PLC
|
$194.04
|
$261.56B | 28.0 | 61 | Compare |
|
NVS
Novartis AG
|
$150.19
|
$254.99B | 20.9 | 52 | Compare |
|
ABT
Abbott Laboratories
|
$102.73
|
$232.30B | 28.1 | 56 | Compare |
|
MRK
Merck & Co., Inc.
|
$117.58
|
$225.13B | 16.3 | 68 | Compare |
|
PFE
Pfizer Inc.
|
$27.53
|
$154.70B | 20.3 | 65 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$46.81
|
$121.27B | 19.9 | 62 | Compare |
More LVTX Analysis
Data updated: Mar 30, 2026 | Industry: PHARMACEUTICAL PREPARATIONS (SIC 2834)
553 stocks in this industry